Endometrial cancer
EC · Oncology · 2 drugs · 2 indications
Cancer of the uterine lining.
Competitive Landscape (2 drugs)
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|
| Rina-S | GMAB | Tissue factor-targeting ADC (Rina-S) | ADC | IV | PHASE3 |
| Keytruda | MRK | PD-1 inhibitor | Antibody | IV | APPROVED |
Indications (2)
Advanced endometrial cancer
Upcoming Catalysts
Sac-TMT + Keytruda - 1L NSCLC - Ph3 - Update (OptiTROP-Lung05)CLINICAL
MRK2026
Rina-S - PROC - Ph2 - Data Update (RAINFOL-01)CLINICAL
GMABH2 2026
Keytruda - LOE PreparationCOMPETITIVE
MRKOngoing
Rina-S - PROC - Accelerated Approval FilingREGULATORY
GMABQ1 2027
Data from Supabase · Updated 2026-03-24